Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 1997;56:287-291; doi:10.1136/ard.56.5.287
Copyright © 1997 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 1997;56:287-291 ( May )

Hypothesis

Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis

T Aigner,a J Dudhiab

a Institute of Pathology, University of Erlangen-Nürnberg, Germany , b Kennedy-Institute of Rheumatology, London

Correspondence to: Dr T Aigner, Institute of Pathology, University of Erlangen-Nürnberg, Krankenhausstr 8-10, D-91054 Erlangen, Germany.

Accepted for publication 11 February 1997

The first 150 words of the full text of this article appear below.

    Introduction

One central hallmark of osteoarthritic cartilage degeneration is the loss of matrix molecules, in particular proteoglycans. However, chondrocytes of osteoarthritic cartilage are generally thought to be anabolically hyperactive. Thus, in osteoarthritic cartilage degeneration, the ongoing net loss of the cartilage matrix components is attributed not to a lack of synthesis of cartilage matrix molecules by the cartilage cells, but to an increase in matrix catabolism by most authors.1-3 In contrast, our in situ analysis on the single cell level showed a suppression of aggrecan and collagen type II expression in the chondrocytes in the upper cartilage zone, which is critical for the progression of the cartilage destruction. Phenotyping of the osteoarthritic chondrocytes in this zone furthermore shows that the decrease in anabolic activity was presumably not simply because of cell deactivation, but may entail a specific cell differentiation pathway taken by the osteoarthritic chondrocytes. Based on our in situ analyses, . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Chubinskaya, S., Huch, K., Schulze, M., Otten, L., Aydelotte, M. B., Cole, A. A. (2001). Gene Expression by Human Articular Chondrocytes Cultured in Alginate Beads. J. Histochem. Cytochem. 49: 1211-1220 [Abstract] [Full Text]  
  • Sylvester, J., Liacini, A., Li, W. Q., Dehnade, F., Zafarullah, M. (2001). Tripterygium wilfordii Hook F Extract Suppresses Proinflammatory Cytokine-Induced Expression of Matrix Metalloproteinase Genes in Articular Chondrocytes by Inhibiting Activating Protein-1 and Nuclear Factor-kappa B Activities. Mol. Pharmacol. 59: 1196-1205 [Abstract] [Full Text]  
  • Plaas, A. H. K., West, L. A., Wong-Palms, S., Nelson, F. R. T. (1998). Glycosaminoglycan Sulfation in Human Osteoarthritis. DISEASE-RELATED ALTERATIONS AT THE NON-REDUCING TERMINI OF CHONDROITIN AND DERMATAN SULFATE. J. Biol. Chem. 273: 12642-12649 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs